Venezuelan Equine Encephalitis Virus Infection: Clinical Trials

2 trials for Venezuelan Equine Encephalitis Virus Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1

Follow Venezuelan Equine Encephalitis Virus Infection: new trials by email Literature Review of Venezuelan Equine Encephalitis Virus Infection trials Research Report on Venezuelan Equine Encephalitis Virus Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers
V4020 - Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection
Phase 1Not yet recruitingMedigen, Inc.392025-08-152025-07-28
Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers
Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection
Phase 1CompletedIchor Medical Systems Incorporated422013-12-012015-08-26

Narrower conditions

Encephalomyelitis, Venezuelan Equine (2)

Broader conditions

Alphavirus Infections (2)  ·  Arbovirus Infections (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Central Nervous System Viral Diseases (2)  ·  Encephalitis (2)  ·  Encephalitis, Arbovirus (2)  ·  Encephalitis, Viral (2)  ·  Encephalomyelitis (2)  ·  Encephalomyelitis, Equine (2)  ·  Infections (2)  ·  Infectious Encephalitis (2)  ·  Mosquito-Borne Diseases (2)  ·  Nervous System Diseases (2)

Sponsors

Ichor Medical Systems Incorporated (1)  ·  Medigen, Inc. (1)

Countries

United States (2)

Results publications

PMID 27206386